Publications
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFN beta2020 | First Faculty of Medicine
- Neuromyelitis optica spectrum disorders - laboratory examination2020 | First Faculty of Medicine
- Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium2020 | First Faculty of Medicine
- Monocyte NOTCH2 expression predicts IFN-beta immunogenicity in multiple sclerosis patients2018 | First Faculty of Medicine
- Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica2016 | First Faculty of Medicine
- Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children2015 | First Faculty of Medicine
- Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus2013 | First Faculty of Medicine
- Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology2012 | First Faculty of Medicine
- Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis2024 | First Faculty of Medicine
Loading network view...